▶ 調査レポート

世界の代謝検査市場

• 英文タイトル:Market Study on Metabolic Testing: Global Market Led by North America, Followed by Asian Region

Persistence Market Researchが調査・発行した産業分析レポートです。世界の代謝検査市場 / Market Study on Metabolic Testing: Global Market Led by North America, Followed by Asian Region / MRC2301E016資料のイメージです。• レポートコード:MRC2301E016
• 出版社/出版日:Persistence Market Research / 2022年10月3日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Site Licence¥1,140,000 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,590,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査資料は、世界の代謝検査市場について総合的・多面的に調査しています。本資料では、エグゼクティブサマリー、市場概要、主要市場動向、ルール・規制、需要分析・予測、価格分析、市場背景、製品別(CPET装置、メタボリックカート、代謝量測定器、ECG・CPET装置取り付け型EKG(心電図)、ソフトウェア)分析、用途別(生活習慣病、クリティカルケア、ヒューマン・パフォーマンス・テスト、代謝不全症候群、その他)分析、技術別(VO2マックス分析、RMR分析、体組成分析)分析、エンドユーザー別(病院、研究所、スポーツトレーニングセンター、ジム、その他)分析、地域別(北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東・アフリカ)分析、構造分析、競争分析、仮定、調査方法などを整理しております。また、CareFusion Corporation、General Electric Company、Geratherm Medical AG、MGC Diagnostics Corporation、OSI Systems, Inc.、AEI Technologies, Inc.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・ルール・規制
・需要分析・予測
・価格分析
・市場背景
・世界の代謝検査市場規模:製品別
- CPET装置の市場規模
- メタボリックカートの市場規模
- 代謝量測定器の市場規模
- ECG・CPET装置取り付け型EKG(心電図)の市場規模
- ソフトウェアの市場規模
・世界の代謝検査市場規模:用途別
- 生活習慣病における市場規模
- クリティカルケアにおける市場規模
- ヒューマン・パフォーマンス・テストにおける市場規模
- 代謝不全症候群における市場規模
- その他における市場規模
・世界の代謝検査市場規模:技術別
- VO2マックス分析における市場規模
- RMR分析における市場規模
- 体組成分析における市場規模
・世界の代謝検査市場規模:エンドユーザー別
- 病院における市場規模
- 研究所における市場規模
- スポーツトレーニングセンターにおける市場規模
- ジムにおける市場規模
- その他における市場規模
・世界の代謝検査市場規模:地域別
- 北米の代謝検査市場規模
- 中南米の代謝検査市場規模
- ヨーロッパの代謝検査市場規模
- 東アジアの代謝検査市場規模
- 南アジアの代謝検査市場規模
- オセアニアの代謝検査市場規模
- 中東・アフリカの代謝検査市場規模
・構造分析
・競争分析
・仮定
・調査方法

Metabolic Testing Market: Report Scope

The latest market report by Persistence Market Research on the global metabolic testing market evaluates the opportunities and current market scenario, providing insights and updates about corresponding segments involved in the market for the forecast period of 2022-2032. The report provides a detailed assessment of key market dynamics and comprehensive information about the structure of the market. This study contains detailed insights into how the market is anticipated to grow during the forecast period of 2022-2032.

The primary objective of the report is to provide insights regarding opportunities in the market that are supporting the transformation of global businesses associated with metabolic testing. It is very important to consider that, in an ever-wavering economy, we provide estimated (Y-o-Y) year-on-year growth rate in addition to the compound annual growth rate (CAGR) for overall forecasts, to enable readers better understand the analysis and evaluation of the market, and to discover lucrative opportunities in this space.

This report also provides an estimate of market size and corresponding revenue forecasts carried out in terms of absolute $ opportunity. It also offers actionable insights based on future trends in the market. Furthermore, new and emerging players in the global metabolic testing market can make use of the information presented in the study for effective business decisions, which will provide momentum to their businesses as well as the global market.

The study is relevant for manufacturers, suppliers, distributors, and investors in the metabolic testing market. All stakeholders, as well as industry experts, researchers, journalists, and business researchers can leverage the information and data represented in the report.

Key Market Segments

Persistence Market Research’s report on the global metabolic testing market offers information divided into five segments – product, application, technology, end user, and region.

Product

CPET Systems
Metabolic Carts
Body Consumption Analyzers
ECGs/EKGs Attachable to CPET Systems
Software
Application

Lifestyle Diseases
Critical Care
Human Performance Testing
Dysmetabolic Syndrome X
Metabolic Disorders
Other Applications
Technology

VO2 Max Analysis
RMR Analysis
Body Composition Analysis
End User

Hospitals
Laboratories
Sports Training Centers
Gyms
Other End Users
Region

North America
Europe
Latin America
East Asia
The Middle East & Africa
South Asia & Pacific
Key Questions Answered in Study

Which region will hold the highest market share over the forecast period?
Which region is experiencing the highest growth (CAGR)?
Which factors are impacting the global metabolic testing industry?
What are the global trends impacting the market?
What strategies must emerge players adopt to capture opportunities in various regions in the market?
What is the structure of the global metabolic testing market?
Research Methodology

Persistence Market Research is committed to providing unbiased market research solutions to its clients. The company follows a robust methodology for the deduction of data included in this report. A unique research methodology is utilized to conduct extensive research on the global metabolic testing market, and reach conclusions about the future growth factors of the market. The research methodology comprises primary research methods coupled with secondary research methods, which ensures the accuracy and reliability of the conclusions in this report.

A demand-side approach is followed to estimate the sales of target products, followed by an in-depth supply-side assessment of value generated, key trends, and events over a predefined period.

This methodology is based on standard market structures, methods, and definitions that are based on inputs from local sources in over six regions – North America, Latin America, Europe, South Asia and Pacific, East Asia, and the Middle East & Africa, which Persistence Market Research considers for segmenting the global market. Statistics, characteristics, and variances are collected at a regional level, aggregated at the same level, and then synthesized at a worldwide level, to create global market measurements.

Our main sources of research include:

Primary Research
Secondary Research
Trade Research
Social Media Research

レポート目次

1. Executive Summary

    1.1. Global Market Overview

    1.2. Summary of Key Statistics

    1.3. Summary of Key Findings

    1.4. Product Evolution Analysis

    1.5. PMR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage/Taxonomy

    2.2. Market Definition/Scope/Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Future Prospects of Metabolic Testing Industry

        3.2.1. Factors Fuelling Growth

        3.2.2. Influx of Brands

        3.2.3. Innovative Distribution & Marketing Strategies

4. Rules and Regulations

    4.1. Warning Labels

    4.2. Regulatory Options for Little Cigars

        4.2.1. Product Description

        4.2.2. Health Risks

        4.2.3. End Usering

        4.2.4. Minimum Pack Technology Regulatory Gap

    4.3. Cigar Labeling and Warning Statement Requirements by FDA

    4.4. Tobacco Control Laws

        4.4.1. Use of E-Cigarettes is Prohibited

        4.4.2. Tobacco Advertising is Prohibited in Mass Media

        4.4.3. Others

    4.5. Others (During the Course of Study)

5. Global Metabolic Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032

    5.1. Historical Market Volume (‘000 Units) Analysis, 2017-2021

    5.2. Current and Future Market Volume (‘000 Units) Projections, 2022-2032

    5.3. Y-o-Y Growth Trend Analysis

6. Global Metabolic Testing Market – Pricing Analysis

    6.1. Pricing Analysis By Product

    6.2. Global Average Pricing Analysis Benchmark

7. Global Metabolic Testing Market Demand (in Value or Technology in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Global Cigar industry Outlook

        8.1.1. Perception of Cigars

        8.1.2. Prevalence of Smoking Cigars among Adults

        8.1.3. Top 10 Cigars & Cigarillo Companies in the World

    8.2. Macro-Economic Factors

        8.2.1. GDP Growth Outlook

        8.2.2. Consumer Spending Outlook

        8.2.3. GDP Growth Rate Analysis

        8.2.4. Income Group Population Overview

        8.2.5. Per Capita Disposable Income

    8.3. Forecast Factors – Relevance & Impact

        8.3.1. Top Companies Historical Growth

        8.3.2. Urbanization Growth Outlook

        8.3.3. Others

    8.4. PESTLE Analysis of Global Metabolic Testing Market

    8.5. Investment Feasibility Matrix of Metabolic Testing Market

    8.6. Porter’s Five Forces Analysis of Global Metabolic Testing Market

    8.7. Market Dynamics

        8.7.1. Drivers

        8.7.2. Restraints

        8.7.3. Opportunity Analysis

9. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Product, 2017 – 2021

    9.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Product, 2022 – 2032

        9.3.1. CPET Systems

        9.3.2. Metabolic Carts

        9.3.3. Body Consumption Analyzers

        9.3.4. ECGs/EKGs Attachable to CPET Systems

        9.3.5. Software

    9.4. Market Attractiveness Analysis by Product

10. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Application, 2017 – 2021

    10.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Application, 2022 – 2032

        10.3.1. Lifestyle Diseases

        10.3.2. Critical Care

        10.3.3. Human Performance Testing

        10.3.4. Dysmetabolic Syndrome X

        10.3.5. Metabolic Disorders

        10.3.6. Other Applications

    10.4. Market Attractiveness Analysis by Application

11. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Technology

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Technology, 2017 – 2021

    11.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Technology, 2022 – 2032

        11.3.1. VO2 Max Analysis

        11.3.2. RMR Analysis

        11.3.3. Body Composition Analysis

    11.4. Market Attractiveness Analysis by Technology

12. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Flavor, 2017 – 2021

    12.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Flavor, 2022 – 2032

        12.3.1. Hospitals

        12.3.2. Laboratories

        12.3.3. Sports Training Centers

        12.3.4. Gyms

        12.3.5. Other End Users

    12.4. Market Attractiveness Analysis by Flavor

13. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Region, 2017 – 2021

    13.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Region, 2022 – 2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis by Region

14. North America Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021

    14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032

        14.4.1. By Country

            14.4.1.1. U.S.

            14.4.1.2. Canada

        14.4.2. By Product

        14.4.3. By End User

        14.4.4. By Application

        14.4.5. By Technology

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By End User

        14.5.4. By Application

        14.5.5. By Technology

15. Latin America Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021

    15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032

        15.4.1. By Country

            15.4.1.1. Brazil

            15.4.1.2. Mexico

            15.4.1.3. Rest of Latin America

        15.4.2. By Product

        15.4.3. By End User

        15.4.4. By Application

        15.4.5. By Technology

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By End User

        15.5.4. By Application

        15.5.5. By Technology

16. Europe Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021

    16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032

        16.4.1. By Country

            16.4.1.1. Germany

            16.4.1.2. Italy

            16.4.1.3. France

            16.4.1.4. U.K.

            16.4.1.5. Spain

            16.4.1.6. Rest of Europe

        16.4.2. By Product

        16.4.3. By End User

        16.4.4. By Application

        16.4.5. By Technology

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By End User

        16.5.4. By Application

        16.5.5. By Technology

17. South Asia Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021

    17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032

        17.4.1. By Country

            17.4.1.1. India

            17.4.1.2. Thailand

            17.4.1.3. Indonesia

            17.4.1.4. Malaysia

            17.4.1.5. Rest of South Asia

        17.4.2. By Product

        17.4.3. By End User

        17.4.4. By Application

        17.4.5. By Technology

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product

        17.5.3. By End User

        17.5.4. By Application

        17.5.5. By Technology

18. East Asia Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021

    18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032

        18.4.1. By Country

            18.4.1.1. China

            18.4.1.2. Japan

            18.4.1.3. South Korea

        18.4.2. By Product

        18.4.3. By End User

        18.4.4. By Application

        18.4.5. By Technology

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Product

        18.5.3. By End User

        18.5.4. By Application

        18.5.5. By Technology

19. Oceania Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021

    19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032

        19.4.1. By Country

            19.4.1.1. Australia

            19.4.1.2. New Zealand

        19.4.2. By Product

        19.4.3. By End User

        19.4.4. By Application

        19.4.5. By Technology

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Product

        19.5.3. By End User

        19.5.4. By Application

        19.5.5. By Technology

20. Middle East and Africa Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032

    20.1. Introduction

    20.2. Pricing Analysis

    20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021

    20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032

        20.4.1. By Country

            20.4.1.1. GCC Countries

            20.4.1.2. Northern Africa

            20.4.1.3. South Africa

            20.4.1.4. Rest of Middle East and Africa

        20.4.2. By Product

        20.4.3. By End User

        20.4.4. By Application

        20.4.5. By Technology

    20.5. Market Attractiveness Analysis

        20.5.1. By Country

        20.5.2. By Product

        20.5.3. By End User

        20.5.4. By Application

        20.5.5. By Technology

21. Key Countries’ Metabolic Testing Market Analysis 2022-2032

    21.1. Introduction

        21.1.1. Market Value Proportion Analysis, By Key Countries

        21.1.2. Global Vs. Country Growth Comparison

    21.2. U.S. Metabolic Testing Market Analysis

        21.2.1. By Product

        21.2.2. By End User

        21.2.3. By Application

        21.2.4. By Technology

    21.3. Canada Metabolic Testing Market Analysis

        21.3.1. By Product

        21.3.2. By End User

        21.3.3. By Application

        21.3.4. By Technology

    21.4. Mexico Metabolic Testing Market Analysis

        21.4.1. By Product

        21.4.2. By End User

        21.4.3. By Application

        21.4.4. By Technology

    21.5. Brazil Metabolic Testing Market Analysis

        21.5.1. By Product

        21.5.2. By End User

        21.5.3. By Application

        21.5.4. By Technology

    21.6. Germany Metabolic Testing Market Analysis

        21.6.1. By Product

        21.6.2. By End User

        21.6.3. By Application

        21.6.4. By Technology

    21.7. Italy Metabolic Testing Market Analysis

        21.7.1. By Product

        21.7.2. By End User

        21.7.3. By Application

        21.7.4. By Technology

    21.8. U.K. Metabolic Testing Market Analysis

        21.8.1. By Product

        21.8.2. By End User

        21.8.3. By Application

        21.8.4. By Technology

    21.9. China Metabolic Testing Market Analysis

        21.9.1. By Product

        21.9.2. By End User

        21.9.3. By Application

        21.9.4. By Technology

    21.10. Japan Metabolic Testing Market Analysis

        21.10.1. By Product

        21.10.2. By End User

        21.10.3. By Application

        21.10.4. By Technology

    21.11. S. Korea Metabolic Testing Market Analysis

        21.11.1. By Product

        21.11.2. By End User

        21.11.3. By Application

        21.11.4. By Technology

    21.12. India Metabolic Testing Market Analysis

        21.12.1. By Product

        21.12.2. By End User

        21.12.3. By Application

        21.12.4. By Technology

    21.13. Australia and New Zealand Metabolic Testing Market Analysis

        21.13.1. By Product

        21.13.2. By End User

        21.13.3. By Application

        21.13.4. By Technology

    21.14. South Africa Metabolic Testing Market Analysis

        21.14.1. By Product

        21.14.2. By End User

        21.14.3. By Application

        21.14.4. By Technology

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies (Metabolic Testing)

    22.2. Market Concentration

    22.3. Market Share Analysis of Top Players

    22.4. Market Presence Analysis

        22.4.1. By Regional footprint of Players

        22.4.2. Product foot print by Players

        22.4.3. Channel Foot Print by Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Pricing Analysis by Competition

    23.3. Competition Benchmarking

    23.4. Competition Deep Dive

        23.4.1. CareFusion Corporation

            23.4.1.1. Overview

            23.4.1.2. Product Portfolio

            23.4.1.3. Profitability by Market Segments (Product/Channel/Region)

            23.4.1.4. Sales Footprint

            23.4.1.5. Strategy Overview

                23.4.1.5.1. Marketing Strategy

                23.4.1.5.2. Product Strategy

                23.4.1.5.3. Channel Strategy

        23.4.2. General Electric Company

            23.4.2.1. Overview

            23.4.2.2. Product Portfolio

            23.4.2.3. Profitability by Market Segments (Product/Channel/Region)

            23.4.2.4. Sales Footprint

            23.4.2.5. Strategy Overview

                23.4.2.5.1. Marketing Strategy

                23.4.2.5.2. Product Strategy

                23.4.2.5.3. Channel Strategy

        23.4.3. Geratherm Medical AG

            23.4.3.1. Overview

            23.4.3.2. Product Portfolio

            23.4.3.3. Profitability by Market Segments (Product/Channel/Region)

            23.4.3.4. Sales Footprint

            23.4.3.5. Strategy Overview

                23.4.3.5.1. Marketing Strategy

                23.4.3.5.2. Product Strategy

                23.4.3.5.3. Channel Strategy

        23.4.4. MGC Diagnostics Corporation

            23.4.4.1. Overview

            23.4.4.2. Product Portfolio

            23.4.4.3. Profitability by Market Segments (Product/Channel/Region)

            23.4.4.4. Sales Footprint

            23.4.4.5. Strategy Overview

                23.4.4.5.1. Marketing Strategy

                23.4.4.5.2. Product Strategy

                23.4.4.5.3. Channel Strategy

        23.4.5. OSI Systems, Inc.

            23.4.5.1. Overview

            23.4.5.2. Product Portfolio

            23.4.5.3. Profitability by Market Segments (Product/Channel/Region)

            23.4.5.4. Sales Footprint

            23.4.5.5. Strategy Overview

                23.4.5.5.1. Marketing Strategy

                23.4.5.5.2. Product Strategy

                23.4.5.5.3. Channel Strategy

        23.4.6. AEI Technologies, Inc.

            23.4.6.1. Overview

            23.4.6.2. Product Portfolio

            23.4.6.3. Profitability by Market Segments (Product/Channel/Region)

            23.4.6.4. Sales Footprint

            23.4.6.5. Strategy Overview

                23.4.6.5.1. Marketing Strategy

                23.4.6.5.2. Product Strategy

                23.4.6.5.3. Channel Strategy

        23.4.7. Cortex Biophysik GmbH

            23.4.7.1. Overview

            23.4.7.2. Product Portfolio

            23.4.7.3. Profitability by Market Segments (Product/Channel/Region)

            23.4.7.4. Sales Footprint

            23.4.7.5. Strategy Overview

                23.4.7.5.1. Marketing Strategy

                23.4.7.5.2. Product Strategy

                23.4.7.5.3. Channel Strategy

        23.4.8. COSMED

            23.4.8.1. Overview

            23.4.8.2. Product Portfolio

            23.4.8.3. Profitability by Market Segments (Product/Channel/Region)

            23.4.8.4. Sales Footprint

            23.4.8.5. Strategy Overview

                23.4.8.5.1. Marketing Strategy

                23.4.8.5.2. Product Strategy

                23.4.8.5.3. Channel Strategy

        23.4.9. Korr Medical Technologies, Inc.

            23.4.9.1. Overview

            23.4.9.2. Product Portfolio

            23.4.9.3. Profitability by Market Segments (Product/Channel/Region)

            23.4.9.4. Sales Footprint

            23.4.9.5. Strategy Overview

                23.4.9.5.1. Marketing Strategy

                23.4.9.5.2. Product Strategy

                23.4.9.5.3. Channel Strategy

        23.4.10. Microlife Medical Home Solutions, Inc.

            23.4.10.1. Overview

            23.4.10.2. Product Portfolio

            23.4.10.3. Profitability by Market Segments (Product/Channel/Region)

            23.4.10.4. Sales Footprint

            23.4.10.5. Strategy Overview

                23.4.10.5.1. Marketing Strategy

                23.4.10.5.2. Product Strategy

                23.4.10.5.3. Channel Strategy

        23.4.11. Parvo Medics, Inc.

            23.4.11.1. Overview

            23.4.11.2. Product Portfolio

            23.4.11.3. Profitability by Market Segments (Product/Channel/Region)

            23.4.11.4. Sales Footprint

            23.4.11.5. Strategy Overview

                23.4.11.5.1. Marketing Strategy

                23.4.11.5.2. Product Strategy

                23.4.11.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology